September 9th, 2021

 

AlphaThera has announced a distribution agreement with Funakoshi Co., Ltd. for distribution of AlphaThera’s oYo-Link® Antibody labeling products throughout Japan. Funakoshi Co., Ltd. is a leading distributor of innovative reagents and research instruments throughout Japan and internationally, serving an extensive network of universities and companies.

 

Since launching its oYo-Link antibody labeling products, AlphaThera has seen growing interest from customers in Japan. As AlphaThera continues its rapid global expansion, this distribution agreement will help AlphaThera effectively deliver the oYo-Link Antibody labeling technology to new researchers.

 

AlphaThera looks forward to collaborating with the Funakoshi team to reach this market and offer an innovative tool for scientists. The oYo-Link Antibody labeling products will soon be available to researchers in Japan through Funakoshi.

 

About Funakoshi Co. Ltd:

 

Funakoshi Co., Ltd. is a leading distributor of research reagents and instruments for the life science fields throughout Japan and other regions. Their corporate mission is to provide high quality products to a broad range of customers in their domestic and international network.

 

Visit their website for more information: https://www.funakoshi.co.jp/